about
Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients.Effects of Type 2 Diabetes Mellitus in Patients on Treatment With Glibenclamide and Metformin on Carvedilol Enantiomers Metabolism.Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant womenChiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: Application to a clinical pharmacokinetic studyPlasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteersEffect of Lercanidipine on the Pharmacokinetics-Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney DiseaseChronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidationSystemic Lupus Erythematosus Activity Affects the Sinusoidal Uptake Transporter OATP1B1 Evaluated by the Pharmacokinetics of AtorvastatinChiral Discrimination of P-glycoprotein in Parturient Women: Effect of Fluoxetine on Maternal-Fetal Fexofenadine Pharmacokinetics
P50
Q38776173-259655B7-2EEB-49D3-89D0-AF40A05767B1Q54235357-23A206ED-A86B-4108-8650-C4FC0081EA11Q57802090-813982CC-09C9-4543-90D5-652D51D6E58BQ62537837-B9685FCE-00DA-49F1-A2A0-7B4D50386EEFQ89469066-9102BB80-1A2E-4712-B834-BCFEA2358436Q92231676-CE30E8BC-3E40-4FE0-9240-76AA49AA59F2Q92946397-E28A9B0E-759D-4A29-A8AC-EC57C45DFBF0Q95940927-2969A388-9A88-43D5-9C56-30B1DD675531Q96582598-375C1018-2F71-4093-962F-8C3F2457346D
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Glauco Henrique Balthazar Nardotto
@en
Glauco Henrique Balthazar Nardotto
@nl
type
label
Glauco Henrique Balthazar Nardotto
@en
Glauco Henrique Balthazar Nardotto
@nl
prefLabel
Glauco Henrique Balthazar Nardotto
@en
Glauco Henrique Balthazar Nardotto
@nl
P108
P31
P496
0000-0001-7024-4252